數位疫苗市場規模、佔有率和成長分析（按類型、部署模式、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球數位疫苗市場規模將達到 22.2 億美元，到 2025 年將達到 24.6 億美元，到 2033 年將達到 55.9 億美元，在預測期（2026-2033 年）內，複合年成長率為 10.8%。

全球關於數位疫苗的研究成果揭示了其透過神經認知訓練和行為引導策略促進行為改變和提升幸福感的巨大潛力。這些工具利用虛擬實境、行動應用和人工智慧等先進技術，旨在以經濟實惠且易於獲取的方式培養良好習慣並改善心理健康。隨著醫療資訊科技的不斷發展，物聯網 (IoT)、穿戴式科技和擴增實境(AR) 等創新技術使得針對各種健康問題的頻繁行為介入成為可能。人工智慧和機器學習正在進一步最佳化數位疫苗系統，提高其準確性和有效性。憑藉這些能力，數位疫苗有望在促進更健康的生活方式和豐富生活體驗方面做出重大貢獻，預示著行為改變和健康促進領域擁有光明的前景。

全球數位疫苗市場促進因素

全球數位疫苗市場正經歷顯著成長，這主要得益於各國政府和醫療機構在對抗感染疾病對疫苗接種計畫日益重視。這種重視程度的提升推動了對創新數位解決方案的需求，這些解決方案能夠簡化和加強疫苗接種活動。諸如用於預約管理和發送提醒的行動應用程式等工具已被證明非常實用，使醫療服務提供者能夠更有效地與目標人群建立聯繫和互動。透過利用這些數位資源，疫苗宣傳活動可以提高效率和覆蓋範圍，最終提高全球社區的疫苗接種率和健康狀況。

限制全球數位疫苗市場的因素

全球數位疫苗市場在敏感健康資訊的收集、儲存和共用方面面臨著許多挑戰，引發了人們對資料隱私和安全的嚴重擔憂。保護個人健康資料並確保疫苗接種記錄的保密性至關重要。安全措施不足可能導致資料外洩和敏感資訊遭到未授權存取，從而損害用戶信任。為了促進數位疫苗系統的廣泛接受和應用，必須透過實施全面的資料保護通訊協定和嚴格的安全措施來解決這些隱私問題，從而確保用戶資料的完整性和保密性。

全球數位疫苗市場趨勢

隨著區塊鏈技術在安全疫苗供應鏈中的應用，全球數位疫苗市場正經歷變革性的趨勢。各相關人員在尋求提高疫苗分發的安全性和透明度，而區塊鏈去中心化、防篡改的帳本系統為確保疫苗的完整性和可追溯性提供了一種創新解決方案。該技術有效降低了假冒產品的風險，並確保整個供應鏈遵守正確的儲存和處理通訊協定。因此，市場正見證著技術提供者和醫療機構之間投資與合作的增加，從而建立一個更具韌性和效率的疫苗供應生態系統，這將有助於加強全球公共衛生工作。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球數位疫苗市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 疫苗管理軟體
• 疫苗接種追蹤應用程式
• 數位平台

全球數位疫苗市場規模（按部署模式和複合年成長率分類）（2026-2033 年）

• 基於雲端的
• 本地部署

全球數位疫苗市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫療保健提供者
• 製藥和生物技術公司
• 政府和公共衛生機構
• 研究機構和學術中心
• 患者和看護者

全球數位疫苗市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Pfizer（US）
• Moderna（US）
• Johnson & Johnson（US）
• AstraZeneca（UK）
• Merck（US）
• Sanofi（France）
• GSK（UK）
• Novavax（US）
• BioNTech（Germany）
• Bharat Biotech（India）
• Microsoft（US）
• IBM（US）
• Oracle（US）
• Salesforce（US）
• Amazon（US）
• Google（US）
• McKesson（US）
• AmerisourceBergen（US）
• CVS Health（US）
• Walgreens Boots Alliance（US）

結論與建議

Global Digital Vaccine Market size was valued at USD 2.22 Billion in 2024 and is poised to grow from USD 2.46 Billion in 2025 to USD 5.59 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

Global insights into digital vaccines reveal their transformative potential in shaping behavioral changes and enhancing well-being through neurocognitive training and nudging strategies. Leveraging advanced technologies, such as virtual reality, mobile applications, and artificial intelligence, these tools are designed to foster positive habits and improve mental health affordably and accessibly. As the healthcare IT landscape evolves, innovations like the Internet of Things, wearable technologies, and augmented reality facilitate frequent behavioral interventions that target diverse health issues. AI and machine learning further optimize digital vaccine systems, enhancing their precision and effectiveness. With such capabilities, digital vaccines stand poised to significantly promote healthier lifestyles and enrich life experiences, indicating a promising future in behavior modification and health improvement across populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Vaccine Market Segments Analysis

Global Digital Vaccine Market is segmented by Type, Deployment mode, End user and region. Based on Type, the market is segmented into Vaccine management software, vaccination tracking applications and digital platforms. Based on Deployment mode, the market is segmented into Cloud-based and on-premise. Based on End user, the market is segmented into Healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers and patients & caregivers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Vaccine Market

The global digital vaccine market is experiencing significant growth driven by the increasing emphasis on immunization programs by governments and healthcare organizations to combat infectious diseases. This rising priority has fueled the demand for innovative digital solutions that streamline and enhance vaccination initiatives. Tools like mobile applications for scheduling appointments and sending reminders are proving invaluable, allowing healthcare providers to connect with and engage targeted populations more effectively. By leveraging these digital resources, vaccination campaigns can improve both their efficiency and reach, ultimately leading to higher vaccination rates and better health outcomes for communities worldwide.

Restraints in the Global Digital Vaccine Market

The Global Digital Vaccine market faces significant challenges related to the collection, storage, and sharing of sensitive health information, which raises critical concerns regarding data privacy and security. Protecting personal health data and ensuring the confidentiality of vaccination records are vital factors in this context. Inadequate security measures may lead to data breaches and unauthorized access to sensitive information, jeopardizing user trust. To foster widespread acceptance and utilization of digital vaccine systems, it is imperative to address these privacy concerns by implementing comprehensive data protection protocols and stringent security measures that reassure users of their data integrity and confidentiality.

Market Trends of the Global Digital Vaccine Market

The global digital vaccine market is experiencing a transformative trend driven by the integration of blockchain technology for secure vaccine supply chains. As stakeholders seek to enhance the security and transparency of vaccine distribution, blockchain's decentralized and tamper-resistant ledger system provides an innovative solution to ensure the integrity and traceability of vaccines. This technology effectively reduces the risk of counterfeit products and ensures adherence to proper storage and handling protocols throughout the supply chain. Consequently, the market is witnessing increased investment and collaboration among technology providers and healthcare organizations, establishing a more resilient and efficient vaccine delivery ecosystem that bolsters public health efforts worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Vaccine Market Size by Type & CAGR (2026-2033)

• Market Overview
• Vaccine management software
• vaccination tracking applications
• digital platforms

Global Digital Vaccine Market Size by Deployment mode & CAGR (2026-2033)

• Market Overview
• Cloud-based
• on-premise

Global Digital Vaccine Market Size by End user & CAGR (2026-2033)

• Market Overview
• Healthcare providers
• pharmaceutical & biotechnology companies
• government & public health agencies
• research institutes & academic centers
• patients & caregivers

Global Digital Vaccine Market Size & CAGR (2026-2033)

• North America (Type, Deployment mode, End user)
  • US
  • Canada
• Europe (Type, Deployment mode, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Deployment mode, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Deployment mode, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Deployment mode, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salesforce (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amazon (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Google (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations